Welcome : Guest

Gen Mark Diagnostics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Gen Mark Diagnostics, Inc., which is principally involved in Molecular Diagnostics Business. Illustrated with 40 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64445
Price: $2000
Company Type: Public
Pages: 43
Date: November 2016
Market Data Tables: 40

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Infectious Disease......4
Table 1: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......4
Molecular Infectious Disease......5
Table 2: Molecular Infectious Disease Market by Panel Worldwide (2015) - Percentage Share Breakdown by Value Sales for BSI +/- (Sepsis), CSF, Enteric (GI), Fungal (Candida), HCV Genotyping, Respiratory, and STI......5
Table 3: Molecular Infectious Disease Diagnostic Equipment Market by Platform Worldwide (2015) - Percentage Share Breakdown by Value Sales for BioFire, LX 100/200 & MAGPIX, MALDI Biotyper, Verigene, XT-8, and Others......6
Gram Infections......7
Table 4: Gram Infection Market by Segment in European Union (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Others......7
Table 5: Gram Infection Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Other......8
Gram-Negative Bloodstream Infections Test......9
Table 6: Gram-Negative Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......9
Gram-Positive Bloodstream Infections Test......10
Table 7: Gram-Positive Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......10
Diagnostics Tests......11
Table 8: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......11
Table 9: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......12
In Vitro Diagnostics (IVD)......13
Table 10: Clinical In-Vitro Diagnostics Market by Disease Worldwide (2015) - Percentage Share Breakdown by Value for Cancers, Infectious Diseases and Others......13
Table 11: In Vitro Diagnostics (IVD) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Cancer, Cardiovascular (CV), Infectious Disease, and Others......14
Table 12: In Vitro Diagnostics (IVD) Reagents Market by Category in France (2015) - Percentage Share Breakdown by Value Sales for Biochemistry, Genetic Tests, Haematology, Immunochemistry, Infectious Immunology, and Microbiology......15
Molecular Diagnostics......16
Table 13: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......16
Table 14: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......17
Table 15: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......18
Table 16: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......19
Table 17: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......20
Table 18: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......21
Table 19: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......22
Table 20: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......23
Table 21: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......24
Table 22: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......25
Table 23: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......26
Table 24: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......27
Table 25: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......28
Table 26: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Other......29
Table 27: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......30
Table 28: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......31
Table 29: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......32
Table 30: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......33
Table 31: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......34
Table 32: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......35
Respiratory Virus Tests......36
Table 33: Respiratory Virus Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......36
Molecular Diagnostics......37
Table 34: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......37
Table 35: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......38
Table 36: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......39
Molecular Infectious Disease Equipment......40
Table 37: Market Shares of Leading Molecular Infectious Disease Diagnostic Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for BioMeriuex, Bruker Corporation, GenMark Diagnostics, Inc., Luminex Corporation, Nanosphere, Inc., and Others......40
Table 38: Market Shares of Leading In Vitro Diagnostics (IVD) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), Bayer AG (BAYN), Becton, Dickinson and Company (BDX), BioMerieux SA (BIM), Bio-Rad Laboratories, Inc. (BIO), Danaher Corporation (DHR), Hologic, Inc. (HOLX), LifeScan, Inc., Ortho-Clinical Diagnostics, Inc., Rogers Corporation (ROG), Siemens AG (SIE), Sysmex Corporation, Thermo Fisher Scientific (TMO), Werfen Group, and Others......41
Table 39: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others......42
Table 40: Market Shares of Leading In-Vitro Diagnostics (IVD) Product Developers Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Beckman Coulter, Inc., Johnson & Johnson, Roche Molecular Systems, Inc., Siemens AG and Others......43